 Vancouver, British Columbia--Newsfile Corp. - March 10, 2020 - FSD Pharma Inc. NASDAQ: HUGE CSE: HUGE FSE: 0K9, a specialty, biotech pharmaceutical RD; company focused on developing, over time, a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract and the musculoskeletal system, is initiating a new study at ... 